Rating History for Altimmune (ALT) by Goldman Sachs

More Stocks Rated by Goldman Sachs | Latest Ratings for ALT
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
4/24/2026 Corinne Johnson Upgrade Neutral
(Sell)		 2.50
(N/A)		 2.89
(2.87)		 -0.69% Details